|Bid||49.62 x 2200|
|Ask||49.80 x 800|
|Day's range||49.54 - 50.52|
|52-week range||42.40 - 66.04|
|Beta (3Y monthly)||0.34|
|PE ratio (TTM)||15.14|
|Earnings date||30 Jul 2019|
|Forward dividend & yield||3.20 (6.33%)|
|1y target est||58.27|
Philip Morris International (PM) reported its second-quarter earnings results on Thursday. The company reported adjusted EPS of $1.46.
FEMSA's (FMX) second-quarter 2019 results are likely to be impacted by ongoing cost headwinds, which should continue to hurt margins. However, its growth efforts might provide some respite.
-- Altria calls for 21 to be the nationwide standard --
Philip Morris International, the company behind Marlboro, is to spend another $100m this year developing its alternative to traditional cigarettes as a global marketing drive intensifies to convert smokers to a new generation of products. Martin King, chief financial officer, said on Thursday that extra funds would be deployed to accelerate innovation of the company’s IQOS product — a cigarette-like device that heats, rather than burns, tobacco. of IQOS in the US, are the latest sign of big tobacco ramping up investment to safeguard the industry’s future.
Altria Group, Inc. will host a live audio webcast on Tuesday, July 30, 2019, at 9:00 a.m. Eastern Time to discuss its 2019 second-quarter business results. Altria will issue a press release containing its business results at approximately 7:00 a.m.
On Friday, Goldman Sachs upgraded Altria Group (MO) from a “neutral” to a “buy” while keeping its price target unchanged at $59.
Philip Morris' (PM) Q2 performance to gain from pricing and advancements in RRPs. However, low cigarette sales volumes are a worry.
Constellation Brands Inc (STZ), a leading producer and marketer of alcoholic beverage brands, is expected to release its Q1 fiscal 2020 earnings results before the bell this Friday, June 28. Our Zacks Consensus Estimate calls for quarterly EPS of $2.07.